Gilbert H Kliman bought stock once, on Aug 9, 2018

Dr. Gilbert H. Kliman, MD, is an independent director of Glaukos Corporation (GKOS) and a long‑time healthcare and medical device investor.( A partner at InterWest Partners since 1996 and managing director since 1999, he leads the firm’s medical device investment team with a focus on ophthalmology and digital health.( At Glaukos, he has served on the board of directors since 2007, with a brief hiatus between August 2019 and March 2020, and continues to be an active corporate insider, including recent trades in Glaukos stock.( As of mid‑2024, he held tens of thousands of Glaukos shares and has executed multiple Form 4‑reported transactions over the past five years.(

Kliman is recognized for pioneering InterWest’s ophthalmology investment franchise, having been an early investor and board member in category‑defining ophthalmic and digital health companies such as Avedro, Glaukos, LenSx, IntraLase, Epocrates, Doximity, Gobiquity, and Restoration Robotics.( A former practicing eye surgeon, he completed an ophthalmology residency at Wills Eye Hospital and a retina fellowship at Massachusetts Eye and Ear Infirmary as a Heed Foundation fellow, after earning a BA from Harvard University, an MD from the University of Pennsylvania, and an MBA from Stanford University.( His dual background in clinical ophthalmology and venture capital underpins his role as a leading board‑level advisor in innovative eye‑care and healthcare technology companies.(

Written by Perplexity from public sources.